Sandoz Strategizes Quick Launch of Generic Ozempic in Canada

Sandoz, a subsidiary of Novartis, has unveiled its plans to swiftly introduce a generic version of the diabetes medication Ozempic in Canada. This move comes amid rising demand for affordable diabetes treatment options in the country, where the cost of medications has been a significant concern for many patients and healthcare providers alike.

Continue reading